Viewing Study NCT01023204


Ignite Creation Date: 2025-12-24 @ 9:16 PM
Ignite Modification Date: 2026-03-11 @ 5:02 PM
Study NCT ID: NCT01023204
Status: COMPLETED
Last Update Posted: 2010-02-04
First Post: 2009-11-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Breast Cancer
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module